TY - JOUR
T1 - Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores
AU - Connolly, John J.
AU - Berner, Eta S.
AU - Smith, Maureen
AU - Levy, Samuel
AU - Terek, Shannon
AU - Harr, Margaret
AU - Karavite, Dean
AU - Suckiel, Sabrina
AU - Holm, Ingrid A.
AU - Dufendach, Kevin
AU - Nelson, Catrina
AU - Khan, Atlas
AU - Chisholm, Rex L.
AU - Allworth, Aimee
AU - Wei, Wei Qi
AU - Bland, Harris T.
AU - Clayton, Ellen Wright
AU - Soper, Emily R.
AU - Linder, Jodell E.
AU - Limdi, Nita A.
AU - Miller, Alexandra
AU - Nigbur, Scott
AU - Bangash, Hana
AU - Hamed, Marwan
AU - Sherafati, Alborz
AU - Lewis, Anna C.F.
AU - Perez, Emma
AU - Orlando, Lori A.
AU - Rakhra-Burris, Tejinder K.
AU - Al-Dulaimi, Mustafa
AU - Cifric, Selma
AU - Scherr, Courtney Lynam
AU - Wynn, Julia
AU - Hakonarson, Hakon
AU - Sabatello, Maya
N1 - Publisher Copyright:
© 2023 American College of Medical Genetics and Genomics
PY - 2023/9
Y1 - 2023/9
N2 - Polygenic risk scores (PRS) have potential to improve health care by identifying individuals that have elevated risk for common complex conditions. Use of PRS in clinical practice, however, requires careful assessment of the needs and capabilities of patients, providers, and health care systems. The electronic Medical Records and Genomics (eMERGE) network is conducting a collaborative study which will return PRS to 25,000 pediatric and adult participants. All participants will receive a risk report, potentially classifying them as high risk (∼2-10% per condition) for 1 or more of 10 conditions based on PRS. The study population is enriched by participants from racial and ethnic minority populations, underserved populations, and populations who experience poorer medical outcomes. All 10 eMERGE clinical sites conducted focus groups, interviews, and/or surveys to understand educational needs among key stakeholders—participants, providers, and/or study staff. Together, these studies highlighted the need for tools that address the perceived benefit/value of PRS, types of education/support needed, accessibility, and PRS-related knowledge and understanding. Based on findings from these preliminary studies, the network harmonized training initiatives and formal/informal educational resources. This paper summarizes eMERGE's collective approach to assessing educational needs and developing educational approaches for primary stakeholders. It discusses challenges encountered and solutions provided.
AB - Polygenic risk scores (PRS) have potential to improve health care by identifying individuals that have elevated risk for common complex conditions. Use of PRS in clinical practice, however, requires careful assessment of the needs and capabilities of patients, providers, and health care systems. The electronic Medical Records and Genomics (eMERGE) network is conducting a collaborative study which will return PRS to 25,000 pediatric and adult participants. All participants will receive a risk report, potentially classifying them as high risk (∼2-10% per condition) for 1 or more of 10 conditions based on PRS. The study population is enriched by participants from racial and ethnic minority populations, underserved populations, and populations who experience poorer medical outcomes. All 10 eMERGE clinical sites conducted focus groups, interviews, and/or surveys to understand educational needs among key stakeholders—participants, providers, and/or study staff. Together, these studies highlighted the need for tools that address the perceived benefit/value of PRS, types of education/support needed, accessibility, and PRS-related knowledge and understanding. Based on findings from these preliminary studies, the network harmonized training initiatives and formal/informal educational resources. This paper summarizes eMERGE's collective approach to assessing educational needs and developing educational approaches for primary stakeholders. It discusses challenges encountered and solutions provided.
KW - Education
KW - Genome-Informed Risk Report
KW - PRS
KW - Polygenic risk score
KW - eMERGE
UR - http://www.scopus.com/inward/record.url?scp=85164255121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85164255121&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2023.100906
DO - 10.1016/j.gim.2023.100906
M3 - Review article
C2 - 37246632
AN - SCOPUS:85164255121
SN - 1098-3600
VL - 25
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 9
M1 - 100906
ER -